WallStreetZenWallStreetZen

NASDAQ: CRSP
Crispr Therapeutics Ag Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for CRSP

Based on 14 analysts offering 12 month price targets for Crispr Therapeutics Ag.
Min Forecast
$30.00-46.64%
Avg Forecast
$80.50+43.19%
Max Forecast
$160.00+184.6%

Should I buy or sell CRSP stock?

Based on 14 analysts offering ratings for Crispr Therapeutics Ag.
Buy
Strong Buy
4 analysts 28.57%
Buy
3 analysts 21.43%
Hold
5 analysts 35.71%
Sell
1 analysts 7.14%
Strong Sell
1 analysts 7.14%

Be the first to know when Wall Street analysts revise their CRSP stock forecasts and price targets.

CRSP stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-05-10
lockedlocked$00.00+00.00%2024-05-09
lockedlocked$00.00+00.00%2024-05-09
lockedlocked$00.00+00.00%2024-05-09
lockedlocked$00.00+00.00%2024-05-09
Baird
Bottom 1%
1
HoldMaintains$52.00-7.51%2024-05-09
Citigroup
Top 9%
92
Strong BuyMaintains$89.00+58.31%2024-04-18
Mizuho
Bottom 16%
16
Strong BuyMaintains$99.00+76.09%2024-03-06
Morgan Stanley
Top 7%
94
Strong SellMaintains$48.00-14.62%2024-02-26
RBC Capital
Bottom 4%
4
HoldMaintains$66.00+17.40%2024-02-22

1 of 2

Forecast return on equity

Is CRSP forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
34.27%

Forecast return on assets

Is CRSP forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

CRSP revenue forecast

What is CRSP's revenue in the next 3 years based on estimates from 12 analysts?
Avg 1 year Forecast
$89.1M-67.2%
Avg 2 year Forecast
$550.1M+102.44%
Avg 3 year Forecast
$1.2B+346.21%
CRSP's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CRSP revenue growth forecast

How is CRSP forecast to perform vs Biotechnology companies and vs the US market?
Company
62.53%
Industry
37.22%
Market
9.95%
CRSP's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CRSP's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CRSP vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CRSP$56.22$80.50+43.19%Buy
MDGL$220.06$345.09+56.82%Buy
KRYS$164.10$185.67+13.14%Strong Buy
NUVL$70.88$101.43+43.10%Strong Buy
APLS$41.31$77.50+87.61%Strong Buy
View Top Biotech Stocks

Crispr Therapeutics Ag Stock Forecast FAQ

Is Crispr Therapeutics Ag Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 14 Wall Street analysts covering (NASDAQ: CRSP) stock is to Buy CRSP stock.

Out of 14 analysts, 4 (28.57%) are recommending CRSP as a Strong Buy, 3 (21.43%) are recommending CRSP as a Buy, 5 (35.71%) are recommending CRSP as a Hold, 1 (7.14%) are recommending CRSP as a Sell, and 1 (7.14%) are recommending CRSP as a Strong Sell.

If you're new to stock investing, here's how to buy Crispr Therapeutics Ag stock.

What is CRSP's revenue growth forecast for 2024-2026?

(NASDAQ: CRSP) Crispr Therapeutics Ag's forecast annual revenue growth rate of 62.53% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.22%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.95%.

Crispr Therapeutics Ag's revenue in 2024 is $271,710,000.On average, 12 Wall Street analysts forecast CRSP's revenue for 2024 to be $7,567,645,694, with the lowest CRSP revenue forecast at $42,459,047, and the highest CRSP revenue forecast at $38,926,453,831. On average, 10 Wall Street analysts forecast CRSP's revenue for 2025 to be $46,710,300,990, with the lowest CRSP revenue forecast at $5,972,289,481, and the highest CRSP revenue forecast at $281,231,740,397.

In 2026, CRSP is forecast to generate $102,955,205,462 in revenue, with the lowest revenue forecast at $9,581,308,433 and the highest revenue forecast at $462,217,672,008.

What is CRSP's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: CRSP) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is CRSP's Price Target?

According to 14 Wall Street analysts that have issued a 1 year CRSP price target, the average CRSP price target is $80.50, with the highest CRSP stock price forecast at $160.00 and the lowest CRSP stock price forecast at $30.00.

On average, Wall Street analysts predict that Crispr Therapeutics Ag's share price could reach $80.50 by May 10, 2025. The average Crispr Therapeutics Ag stock price prediction forecasts a potential upside of 43.19% from the current CRSP share price of $56.22.

What is CRSP's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: CRSP) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.